<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Angelis Consulting Group | Jefferson | Activity</title>
	<link>https://angelisconsulting.com/members/spongeturnip85/activity/</link>
	<atom:link href="https://angelisconsulting.com/members/spongeturnip85/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Jefferson.</description>
	<lastBuildDate>Thu, 20 Aug 2026 06:17:16 -0500</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">4d29e574acaf41b4b51cc646d83b3895</guid>
				<title>Jefferson posted an update: Multiple Myeloma Attorney: How Legal Help Can Support [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/53014/</link>
				<pubDate>Tue, 18 Aug 2026 04:22:58 -0500</pubDate>

									<content:encoded><![CDATA[<p><strong>Multiple Myeloma Attorney: How Legal Help Can Support Patients Seeking Compensation</strong> </p>
<p><em>Informative · Third‑Person · Approximately 1,080 words</em> </p>
<p>Introduction</p>
<p>Multiple myeloma is a plasma‑cell cancer that can develop after extended exposure to certain carcinogens, including asbestos, talc containing asbestos‑like fibers, benzene, and som&hellip;<span class="activity-read-more" id="activity-read-more-53014"><a href="https://angelisconsulting.com/activity/p/53014/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">ed832fe0469485d1435cbe8afbb709f8</guid>
				<title>Jefferson posted an update: Understanding Multiple Myeloma Settlements: Compensation, [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/52888/</link>
				<pubDate>Tue, 18 Aug 2026 03:54:25 -0500</pubDate>

									<content:encoded><![CDATA[<p>Understanding Multiple Myeloma Settlements: Compensation, Process, and Key Considerations</p>
<p>Multiple myeloma, a cancer of plasma cells in the bone marrow, provides a significant health challenge for countless people each year. While advances in treatment have improved survival rates, the monetary problem associated with diagnosis, continuous&hellip;<span class="activity-read-more" id="activity-read-more-52888"><a href="https://angelisconsulting.com/activity/p/52888/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">63f0b82baf3e08878b7fdbf13a1042ef</guid>
				<title>Jefferson posted an update: Multiple Myeloma Attorneys: How Legal Help Can Support [&#133;]</title>
				<link>https://angelisconsulting.com/activity/p/52831/</link>
				<pubDate>Tue, 18 Aug 2026 03:36:35 -0500</pubDate>

									<content:encoded><![CDATA[<p><strong>Multiple Myeloma Attorneys: How Legal Help Can Support Patients and Families</strong> </p>
<p><em>A helpful guide for anybody impacted by multiple myeloma who is considering pursuing a legal claim.</em> </p>
<p>Introduction</p>
<p>Multiple myeloma is a malignant plasma‑cell disorder that represents approximately 1.8% of all cancer identifies in the United States each y&hellip;<span class="activity-read-more" id="activity-read-more-52831"><a href="https://angelisconsulting.com/activity/p/52831/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">0e5c3d0a808ffe6eab8534b80abc59f4</guid>
				<title>Jefferson became a registered member</title>
				<link>https://angelisconsulting.com/activity/p/52809/</link>
				<pubDate>Tue, 18 Aug 2026 03:29:24 -0500</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>